Table 2. Comparison of laboratory parameters of the study groups.
| Variables | Baseline IRA flow | p | |
| Occluded group | Patent group | ||
| TIMI flow 0/1 (n = 70) | TIMI flow 2/3 (n = 18) | ||
| Hemoglobin, g/dl | 13.64 ± 1.62 | 13.29 ± 1.44 | 0.417 |
| White blood cell count, ×109/L | 12.78 ± 2.79 | 11.03 ± 2.02 | 0.015 |
| Neutrophil, ×109/L | 10.17 ± 2.58 | 8.87 ± 1.76 | 0.047 |
| Lymphocyte, ×109/L | 1.80 (0.90-4.00) | 2.00 (1.00-3.10) | 0.157 |
| Platelet count, ×109/L | 241.36 ± 53.75 | 235.61 ± 48.39 | 0.681 |
| Glucose, mg/dL | 122.80 ± 20.70 | 119.67 ± 13.34 | 0.438 |
| Creatinine, mg/dL | 0.98 ± 0.14 | 1.00 ± 0.14 | 0.577 |
| Urea, mg/dL | 36.63 ± 10.07 | 37.28 ± 9.39 | 0.805 |
| Uric acid, mg/dL | 6.47 ± 1.53 | 6.08 ± 0.94 | 0.296 |
| Sodium, mEq/L | 132.91 ± 4.03 | 135.44 ± 2.03 | < 0.001 |
| Potassium, mEq/L | 4.06 ± 0.38 | 4.11 ± 0.32 | 0.564 |
| Total cholesterol, mg/dL | 182.21 ± 31.83 | 176.78 ± 22.45 | 0.498 |
| LDL cholesterol, mg/dL | 118.96 ± 24.30 | 117.11 ± 20.48 | 0.768 |
| HDL cholesterol, mg/dL | 37.27 ± 5.58 | 38.67 ± 5.85 | 0.351 |
| Triglyceride, mg/dL | 173.61 ± 23.16 | 171.28 ± 15.39 | 0.612 |
| Peak troponin I, ng/mL | 48.70 (16.50-87.19) | 30.48 (14.69-58.79) | 0.001 |
| N-terminal proBNP, pg/mL | 806.50 (181.32-4586.20) | 252.11 (58.65-1197.30) | 0.001 |
| Copeptin, ng/mL | 12.13 (2.20-27.24) | 3.94 (2.70-6.80) | < 0.001 |
BNP, brain natriuretic peptide; HDL, high-density lipoprotein; IRA, infarct-related artery; LDL, low-density lipoprotein; SD, standard deviation; TIMI, thrombolysis in myocardial infarction.
Numerical parameters were expressed as mean ± SD or median (min-max). Categorical variables were expressed as numbers and percentage.